Ginsenoside Rg5 Improves Radiation‐Induced Heart Injury via PPARG / PDK1 / AKT1 Pathway
Journal of Cellular and Molecular Medicine · 2025
DOI: 10.1111/jcmm.70852 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2025. Verfasst von Dao-Ming Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Renmin Hospital of Wuhan University, Wuhan, People's Republic of China. Hauptthemen laut MEDLINE: Ginsenosides, PPAR gamma, Proto-Oncogene Proteins c-akt, Signal Transduction. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Hubei Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Ginsenoside Rg5 (G‐Rg5), a rare extract of ginseng, has proven to be valuable for a wide range of clinical applications. However, the role of G‐Rg5 in radiation‐induced heart injury is currently unclear. This study aims to explore the intervention effect and possible treatment mechanism of G‐Rg5 on radiation‐induced heart injury. We investigated the impact of G‐Rg5 on radiation‐induced heart injury through in vivo and in vitro studies. Network pharmacology was employed to explore potential key targets and molecular mechanisms. Various experimental methods were utilised to validate the effects of G‐Rg5 on the PPARG/PDK1/AKT1 pathway. G‐Rg5 alleviated radiation‐induced cardiomyocyte apoptosis and cardiac functional impairment. The expression of peroxisome proliferator activated receptor gamma (PPARG) was upregulated following G‐Rg5 treatment, thereby suppressing the transcription of phosphoinositide‐dependent protein kinase 1 (PDK1), a predicted target gene regulated by PPARG, to enhance AKT serine/threonine kinase 1 (AKT1) phosphorylation levels. The protective effect of G‐Rg5 against radiation‐induced heart injury was found to be compromised upon inhibition or knockdown of PPARG. The interaction between PPARG and PDK1 was confirmed by the results of chromatin immunoprecipitation and luciferase reporter assays. G‐Rg5, through the upregulation of PPARG expression, induces the transcription of PDK1 and subsequently enhances the phosphorylation levels of AKT1. Ultimately, this process plays a crucial role in mitigating cellular apoptosis and functional decline in radiation‐induced heart injury. Therefore, G‐Rg5 holds great potential as a therapeutic agent for radiation‐induced heart injury.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, Renmin Hospital of Wuhan University, Wuhan, People's Republic of China.
- CCU, Renmin Hospital of Wuhan University, Wuhan, People's Republic of China.
- Key Laboratory for Molecular Enzymology and Engineering of the Ministry of Education, School of Life Sciences, Jilin University, Changchun, People's Republic of China.
- Department of Obstetrics and Gynecology, Renmin Hosptial of Wuhan University, Wuhan, People's Republic of China.
ORCID-Profile: Dao-Ming Zhang
Förderung
- Natural Science Foundation of Hubei Province
- National Natural Science Foundation of China
Zitieren
APA
Zhang, D. M., Deng, J. J., Li, H. Y., Shen, Y., Li, Y., Wu, B., Hu, Y., Zou, Y., Huang, Q., & Xu, X. M. (2025). Ginsenoside Rg5 Improves Radiation‐Induced Heart Injury via PPARG / PDK1 / AKT1 Pathway. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70852
Vancouver
Zhang DM, Deng JJ, Li HY, Shen Y, Li Y, Wu B, et al. Ginsenoside Rg5 Improves Radiation‐Induced Heart Injury via PPARG / PDK1 / AKT1 Pathway. Journal of Cellular and Molecular Medicine. 2025. doi:10.1111/jcmm.70852
BibTeX
@article{Zhang2025,
author = {Zhang, Dao-Ming and Deng, Jun-Jian and Li, Hao-Yue and Shen, Yang and Li, Yang and Wu, Bing and Hu, Yan and Zou, Ya and Huang, Qin and Xu, Xi-Ming},
title = {Ginsenoside Rg5 Improves Radiation‐Induced Heart Injury via PPARG / PDK1 / AKT1 Pathway},
journal = {Journal of Cellular and Molecular Medicine},
year = {2025},
doi = {10.1111/jcmm.70852}
}
EUVIMED